LAZCLUZE (lazertinib) — NDC 57894-080 by Janssen Biotech, Inc.
LAZCLUZE (lazertinib) — NDC 57894-080 by Janssen Biotech, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: LAZCLUZE; Generic name: lazertinib; Product NDC: 57894-080.
| Brand name | LAZCLUZE |
|---|---|
| Generic name | lazertinib |
| Product NDC | 57894-080 |
| Labeler | Janssen Biotech, Inc. |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Active ingredients | LAZERTINIB 80 mg/1 |
| Pharmacologic class | Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA] |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →